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ABSTRACT Transcription of the POLI gene of Saccharo-
myces cerevisiae, which encodes DNA polymerase a, the DNA
polymerase required for the initiation ofDNA replication, has
previously been shown to be cell cycle regulated. To understand
how the POLI gene senses cell cycle position, we have inves-
tigated the cis-acting elements that respond to the factors that
govern cell cycle progression. In this report we demonstrate
that a region of 54 nucleotides containing the repeated element
ACGCGT, which conforms to an Mlu I restriction endonucle-
ase recognition site, contains all information necessary for
transcriptional activation and cell cycle responsiveness. Al-
though oligonucleotides lacking either one or both of the
repeated Mlu I sites can function as an upstream activating
sequence, the presence of at least one Mlu I site stimulates
expression and, moreover, is absolutely essential for cell cycle
regulation. A synthetic oligonucleotide corresponding to a
19-base-pair sequence in the POLI promoter containing one
Mlu I site can function as an autonomous cell cycle-responsive
upstream element (upstream activation sequence) with tempo-
ral regulation indistnushable from that previously described
for the POLl gene. Thus, the Mmu I site is an essential part of
a cis-acting element responsible for the observed periodic
activation. This sequence differs from previously defined cell
cycle-responsive transcriptional control elements in the yeast
HO endonuclease and histone genes. We also present evidence
for a negative regulatory element in the 5' flanking region ofthe
Mlu I upstream activation sequence.
Cell cycle-regulated genes in the budding yeast Saccharo-
myces cerevisiae fall into several classes based on the time of
expression in the cell cycle and the function of the gene
products. The DNA replication genes, for example, undergo
a burst of transcription at a point late in the G1 phase of the
cell cycle just before the periodically regulated histone genes
are activated (for review, see ref. 1). The fact that such genes
are expressed at a discrete time during the cell cycle implies
that they are somehow responsive to the molecules that
regulate the cell cycle. The study of such cell cycle-regulated
genes should, therefore, provide insights into the basic mech-
anisms involved in controlling orderly cell cycle progression.
We have been interested in the regulation of POL) (2, 3),
which encodes DNA polymerase a, the polymerase thought
to be involved in the initiation of DNA replication. The
periodic regulation of POLI is well documented (4, 5).
Furthermore, in cells arrested by a-factor or a cdc28 tem-
perature-sensitive mutation, transcription was suppressed
(4). CDC28 encodes the 34-kDa subunit of a protein kinase
thought to be critical in initiating a cascade of events culmi-
nating in the initiation ofDNA synthesis (6). By understand-
ing how POL) transcription responds to CDC28, we may be
able to define events set in motion by CDC28. As a prereq-
uisite to such studies, we have carried out experiments
designed to define the upstream elements that regulate the
POLl promoter.
Many other genes involved in DNA metabolism have been
shown to have similar temporal regulation: POL3 (7), P0L30
(8), CDC8 (9), CDC9 (10), CDC21 (11), PRII (12), PRI2 (13),
and TS26 (14). Comparison of the promoters of these genes
revealed the presence of one or two copies of the 6-base-pair
(bp) consensus sequence ACGCGT, at about the same po-
sition in each promoter. This sequence conforms to the
recognition site for the restriction enzyme Ml-u I. It has been
proposed that the Mlu I site is part of a cis-acting site
responsible for the cell cycle regulation of these promoters
(15, 16).
Here we identify cis-acting sequences in the POLI pro-
moter that are at least partly responsible for the complex
regulation of the POLI gene. We show that a 19-bp oligonu-
cleotide containing one Mlu I site is sufficient to act as an
upstream activation sequence (UAS) with the same pattern of
cell cycle regulation as the chromosomal POLI gene. McIn-
tosh et al. (17) have come to similar conclusions about the
regulation of CDC21.
MATERIALS AND METHODS
Strains. All plasmid propagation and subcloning were
carried out in Escherichia coli HB101 (18). S. cerevisiae
bar)-) (Mata, bar)-), rme, leu), met, trpS, ura3, can], cir+)
was used exclusively for all yeast manipulations (obtained
from Ambrose Jong, University of Southern California Med-
ical School, Los Angeles). The bar]-) mutation reduces
degradation of a-factor (19). Cells were synchronized ac-
cording to Mendenhall et al. (20). The budding index after
a-factor release was determined on plasmid-containing and
plasmid-free cells under the same growth conditions, and
only very slight differences were observed.
Plasidds. pLacZSal is a derivative of pSEYC102 (21) con-
structed by inserting a Sal I linker into the single Sma I site
(Carl Parker, personal communication). PlasmidpLGABS (22)
contains a CYC)-IacZ fusion gene lacking a functional yeast
UAS.
Construction of the POL-I-acZ Fusion Gene. All sites in the
POLI gene are referred to by the numbering system used in
Pizzagalli et al. (16). A POL)-4acZ gene fusion was con-
structed using the POLl fragment from the EcoRI site at
position -2333 to position +343 bp in the POLl gene inserted
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into the EcoRI-BamHI sites of the vector pLacZSal to give
pBS(PD1) (see Fig. 1).
Promoter Deletions. The Sal I-BamHI fragment from pBS-
(PD1) was subcloned into placZSal to give pPD1-1 (Fig. 1).
Plasmid pPD1-2 was constructed by digesting pPD1-1 with
HindIll and religating, creating an internal deletion from
-435 to -376 bp in POLL. Plasmid pPD1-3 was made by
cutting pPD1-1 with EcoRI and HindIll, filling-in the ends
with the Klenow fragment of DNA polymerase I, and recir-
cularizing the plasmid. Thus, pPD1-3 lacks all the POLI
promoter sequences 5' to -375 bp. pPD14 was constructed
in three parts. (i) The Sal I-BamHI fragment from pBS(PD1)
was subcloned into the Stratagene Bluescript vector to give
pBS(PD1-1). (ii) pBS(PD1-1) was digested with Mlu I and
religated generating an internal deletion from -207 to -173
bp but regenerating a single Mlu I site. (iii) The Sal I-BamHI
fragment was inserted into the placZSal. The plasmid pPD1-5
is similar to pPD1-4 except that the Mlu I sticky ends were
removed with S1 nuclease before religating and subcloning
into placZSal. Therefore, the internal promoter deletion in
this plasmid is from -207 to -169 bp.
Promoter Fusions. Plasmid pPU1 contained the 60-bp oli-
gonucleotide PU1 cloned into the plasmid pLGABS. pPU1
contains 54 bp ofPOLI sequence from -217 to -164 bp plus
6 bp to reconstitute the Sal I and Bgl II sites after insertion
into pLGABS. The POLI sequence in PU1 is TCTAT-
TCAAACGCGTTAAAATTTTTTTGTTAGCCTATAAG-
TAAAACGCGTCGCG.
Similarly, the plasmid pPU2 contains a similar 54-bp oli-
gonucleotide to PU1 except that the Mlu I site from -173 to
-168 bp has been deleted. pPU3 contains a 54-bp oligonu-
cleotide missing the Mlu I site from -208 to -203 bp. Finally,
pPU4 contains a 48-bp oligonucleotide missing both Mlu I
sites. pPU5 contains a 25-bp oligonucleotide missing the
sequence between the two Mlu I sequences in PU1 but
retaining a single reconstituted Mlu I site. Therefore, it
contains 19 bp present in the POLI promoter. To construct
plasmid pPU7, the Sal I-Mlu I POLI fragment (bp -683 to
-204) was purified and the 11-bp oligonucleotide PU7 was
synthesized. PU7 had Mlu I and BglII cohesive ends enabling
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FIG. 1. Deletion analysis of the POLI promoter. The diagram
shows the POLI promoter and the location of the two Mlu I sites as
hatch marks under the Mlu I label. A POLIJ-acZ in-frame gene
fusion was constructed in the vectorplacZSal. The effects of various
promoter deletions on transcription were then estimated by the
amount of8-galactosidase activity obtained (23). 3-Galactosidase
activity was given in Miller units (24) and represents the average of
two determinations or two individual transformants. Coordinates are
relative to the ATG translation start site of the POLI gene.
it to ligate to the Sal I-Mlu I fragment to give a Sal I-Bgl II
fragment that contained all the PU5 sequence plus all the
POLI promoter 5' up to the Sal I site at -683 bp. The Sal
I-Mlu I fragment, the PU7 oligonucleotide, and pLGABS
were ligated together and the plasmid pPU7, containing the
desired construct, was verified (see Fig. 2). Plasmid pPU8
was prepared by purifying the Mlu I-Bgl II fragment from
pPU5. Dimerization of this fragment through the Mlu I site
and insertion into the Bgl II site of pLGABS gives rise to a
construct containing the 3' Mlu I site and the 4-bp sequence
CGCG 3' to that region from POLl but no other sequences.
RESULTS
Promoter Deletions. To identify cis-acting sites involved in
the regulation of expression, a POLI-lacZ fusion was con-
structed in the vector placZSal. As shown in Fig. 1, yeast
cells carrying pPD1 (-2333 bp to +343 bp in POLl) had 12
times more f3-galactosidase activity than cells with placZSal.
To define the extent of the POLI promoter, a series of
deletions were introduced into the pPD1 vector (see Fig. 1).
To estimate the effect of each promoter deletion on POLI
gene expression, the level of 8-galactosidase activity in
cultures of cells carrying each plasmid was determined, as
shown in Fig. 1.
Two main conclusions can be drawn. (i) Since no dramatic
drop in activity occurred when 1958 bp from -2333 bp to
-375 bp was removed, a 375-bp DNA fragment is sufficient
for activating transcription. (ii) The 29 bp between the two
Mlu I sites are important for activating transcription, since
the removal of this region caused the level of activity to drop
to that of the plasmid placZSal without any insert. It is
interesting to note that this reduction in the level of the
f3-galactosidase activity was observed even though the plas-
mid carrying this deletion (pPD1-4) retains one intact Mlu I
site. Thus, the Mlu I site alone is not sufficient to promote
transcription in the context of the POLI promoter.
Activity of POLI Promoter Sequences in a UAS Tester
Plasmid. Our results suggest that the POLl sequence be-
tween the two Mlu I sites acts as a positive effector of
transcription. If this conclusion were correct, we would
expect that an oligonucleotide corresponding to this se-
quence should act as a UAS and activate transcription from
a heterologous promoter. To assay for autonomous UAS
activity, various sequences from the POLI promoter were
tested for their ability to promote transcription in plasmid
pLGABS (22), which contains a CYCIJ-acZ fusion gene
lacking a functional UAS. The UAS activity of a DNA
sequence can be estimated by measuring the f3-galactosidase
activity obtained when the tester sequence is present in
pLGABS. Consistent with promoter-deletion studies, when
the Sal I-Mlu I (bp -683 to -204) fragment was cloned into
pLGASB, no p-galactosidase was expressed (Fig. 2). Next, a
double-stranded oligonucleotide, PU1, containing 54 bp of
the POLI promoter from -217 bp to -164 bp spanning both
Mlu I sites and including 9 bp upstream and 4 bp downstream
of these sites was synthesized and cloned into pLGABS. As
shown in Fig. 2, yeast cells containing the PU1 oligonucle-
otide pPU1 had almost 100 times more f3-galactosidase ac-
tivity than cells carrying pLGABS with no insert. This
observation clearly demonstrates that a single copy of PU1
can function as a UAS in yeast.
To investigate if PU1 functioned as a cell cycle-regulated
UAS, a synchronous culture of a strain carrying pPU1 was
prepared by a-factor block/release. Samples were taken at
10-min intervals after removal of a-factor, and primer-
extension analysis was used to determine the amount of
CYCI-lacZ transcript present. The results obtained are
shown in Fig. 3a. When using the lacd primer, which is
specific for thelacZ portion of the CYC1-lacZ fusion mRNA,
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FIG. 2. Activity ofvarious POLI promoter sequences in the UAS
tester plasmid pLGABS. The figure shows diagrammatically the
essential features of plasmid pLGABS. The plasmid contains a
CYCI)-acZ fusion gene lacking a functional UAS. UAS activity was
estimated by introducing the different plasmid constructs into yeast
and assaying the amount of f-galactosidase obtained. The POLI
promoter sequences tested are shown. Sequence a is the fragment
from -204 to -683 bp. Sequence b is the 54-bp oligonucleotide POLI
sequence present in the PU1 and its derivatives PU2, PU3, and PU4.
The presence or absence of the Mlu I sites in each oligonucleotide is
shown by + or -, respectively. Sequence c is oligonucleotide PU5
that is missing the 35-bp sequence interval between the two Mlu I
sites but with a single Mlu I site reconstituted.
four main extension products were obtained that correspond
to the sites expected if the previously determined CYCI
transcription start signals were being used (ref. 25; data not
shown). Fig. 3a clearly demonstrates that the level of these
products varies dramatically during the cell cycle. First, cells
blocked by a-factor in early G1 phase do not transcribe the
test gene in pPU1 (first two samples after a-factor release,
Fig. 3a). Thus, pPU1 responds to the same suppression of
transcription in early G1 phase as described for the POLI
gene (5). Second, the PUl-driven CYC1-lacZ transcripts
appear periodically in the synchronous cycle after removal of
a-factor. Furthermore, timing of the peaks in CYC1-lacZ
transcript level is the same as observed for the POLl mRNA.
This was determined by correlating the variation in transcript
level with the budding index and comparing this periodicity
with the reported fluctuation of the POLl transcript (refs. 4
and 5 and unpublished results). As an aperiodic control, the
same RNA samples were subjected to primer-extension
analysis using ACTi, a primer specific for actin mRNA. The
level of ACT1 primer-extension products remained constant
during the experiment (Fig. 3a). These results clearly show
that the 54-bp segment of POLI present in PU1 contains all
the information required to act as a cell cycle-regulated UAS
with temporal regulation identical to the POLI gene.
An Mlu I Site Is Required for Cell Cycle Regulation. To
investigate the role of the Mlu I sites, oligonucleotides PU2,
PU3, and PU4 were synthesized. PU2 contains the same
DNA sequence as PU1 but lacks the 3' Mlu I site. PU3 is
C
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FIG. 3. Level of CYC1-lacZ and actin mRNA in synchronous
cultures of cells carrying various synthetic UASs. Synchronous
cultures of cells containing various synthetic UASs were prepared by
a-factor block/release. The synchronous cultures were sampled
every 10 min and total RNA was prepared. The level of CYC14acZ
and actin transcript was then investigated by primer-extension
analysis (25) using primers specific for CYC)-IacZ, CGCGCGG-
GAGAGGCGGTTTGCG, or ACTi, GGGAAGACAGCACGAG-
GAGGGTC, in strain bar).) + pPU1 (a), strain bar).) + pPU2 (b),
strain bar).) + pPU4 (c), and strain bar).) + pPU5 (d). For
reference, the presence or absence ofMlu I sites is shown. In b, the
first primer-extension reaction using the lacd primer, specific for
CYC1-lacZ mRNA, gave an aberrant result. Other primer-extension
reactions using lacd with the same RNA sample repeatedly gave low
levels ofCYC1-lacZ mRNA (data not shown). All experiments were
repeated at least twice.
missing the 5' Mlu I site; PU4 lacks both Mlu I sites (see Fig.
2). The data shown in Fig. 2 demonstrate that the p-galac-
tosidase activity observed in asynchronous cultures of cells
carrying pPU2 or pPU3, in which only one of the two Mlu I
sites found in PU1 was present, was only slightly lower than
that measured for cells carrying pPU1 (76 and 83%, respec-
tively). However, for cells containing pPU4, in which both
Mlu I sites were deleted, the /3-galactosidase activity was -5
times lower than the value obtained for cells with pPU1. The
levels of 3-galactosidase in the absence of Mlu I sites is still
14-fold higher than for cells carrying the vector pLGABS
without any insert, however. These results support two
conclusions. (i) One Mlu I site is sufficient for UAS function,
but either Mlu I site alone (that in PU2 or PU3) is almost as
efficient as the two together. (ii) Neither Mlu I site alone
constitutes the sole UAS in the POLI promoter, since the
region between the two Mlu I sites by itself has substantial
transcriptional activation activity and since deletion of these
sequences in the context of the POLI promoter leads to loss
of transcriptional activation (see Fig. 1).
To investigate the role of the Mlu I sites in cell cycle
regulation, the level ofCYC1-lacZ transcript was determined
in synchronous cultures of strains containing either pPU2
(one Mlu I site) or pPU4 (no Mlu I sites). As with strains
carrying pPU1, the level ofCYC1lacZ transcript was found
to vary periodically during the cell cycle in strains carrying
pPU2. The timing of the peaks, at samples 4 and 12, was the
same as that obtained with pPU1. The actin levels, as
expected, remained constant throughout the experiment.
With pPU4, lacking both Mlu I sites, by contrast, the level of
the CYC1-lacZ transcript stayed relatively constant during
the cell cycle. Only in the first two samples after a-factor
release, as with the strains containing all the plasmids tested,
was the amount ofCYC1-lacZ transcript low. Once again the
levels of the actin transcript used as an aperiodic control
remained constant.
Two main conclusions can be inferred from the results
obtained with synchronous cultures. (i) At least one Mlu I site
is essential for proper timing of POLl expression in the cell
cycle, since removal of both Mlu I sites from the PU1 UAS
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eliminates the periodic regulation of the CYC1-lacZ tran-
script. (ii) The presence of a single Mlu I site is sufficient to
entrain proper timing of the POLl expression. These results
strongly suggest that the Mlu I site is part of a cis-acting DNA
sequence responsible for cell cycle regulation of the POLI
gene. (iii) A third result worth noting is that, in the synchro-
nous culture containing pPU4 (Fig. 3c), although the CYC1-
lacZ transcript level was found to be relatively constant
during most of the cycle, it was still almost undetectable in
the first two samples taken after a-factor release. The results
in Fig. 3 a and c raise the intriguing possibility that transcrip-
tion driven by the UAS sequences lying between the Mlu I
sites still responds to the early G1 phase restriction imposed
by a-factor but does not respond to any early G1 phase
restriction in the cell cycles after a-factor release.
Minimal Sequence Requirement for the Mlu I-Containing
UAS. An oligonucleotide missing the 35 bp between the two
Mlu I sites but retaining a hybrid Mlu I site was synthesized
(PU5). As no B-galactosidase activity could be detected in
cells carrying pPD1-6, which contains the same deletion (Fig.
1), little 8-galactosidase activity was expected from the
PU5-driven CYCJ-lacZ gene. Surprisingly, however, the
level of P-galactosidase observed with pPU5 was only slightly
lower than that obtained with pPU2 or pPU3 and four times
higher than that found with pPU4 (Fig. 2). In addition, the
transcription was cell cycle regulated (Fig. 3d) with the same
timing as the chromosomal POLI gene. Thus, the entire
region between the Mlu I sites is dispensable for cell cycle
regulation. Since the 5' Mlu I site plus 4 bp 3' to it are
functional, the minimal essential site is the 15 bp.
The fact that PUS acts as a functionally regulated UAS was
surprising because the PU5 sequence is present in pPD1-4,
one of the promoter deletions that conferred little transcrip-
tional activity on the POLI-lacZ fusion (see Fig. 1). One
explanation is that POLI promoter sequences upstream of
the PU5 sequence in pPD1-4 somehow repress the PU5 UAS
activity. To test this possibility, the region from -683 to -217
bp in the POLI promoter was cloned upstream of PU5 in
pPU5 to give pPU7. The result shown in Fig. 2 demonstrates
that the amount of 8-galactosidase activity obtained with
cells carrying pPU7 was less than 1o of that found with
pPU5. These results are entirely consistent with the results
observed with pPD1-4. Therefore, it appears that a sequence
between -683 and -217 bp in the POLI promoter represses
the "potential" high UAS activity of the sequence encoded
by the PU5 oligonucleotide.
Finally, a 10-bp UAS was constructed containing only the
3' Mlu I site and 4 bases 3' to it-ACGCGTCGCG. This
sequence functioned efficiently (59 units of B-galactosidase
activity) leaving a minimal size of 10 bp for the UAS.
DISCUSSION
This report describes the identification of a cell cycle-
regulated transcriptional control element in S. cerevisiae. We
show that the 6-bp Mlu I sites found twice in the POLl
promoter are part of cis-acting sites responsible for the cell
cycle regulation of the yeast POLI gene. The critical exper-
iments involved testing various regions ofthePOL1 promoter
for UAS activity by inserting the appropriate synthetic DNA
oligonucleotides into a plasmid that contains a CYCI-lacZ
fusion gene lacking a functional CYCJ UAS. We propose that
this cis-acting sequence be called the Mlu I-containing cell
cycle box or MCB element. The fact that the MCB site can
confer periodic regulation on a heterologous CYCI-lacZ
fusion gene, which contains no POLl sequences, indicates
that the cell cycle regulation must be, at least partly, at the
level of transcription. These experiments provide no evi-
dence for or against a second level of control on the periodic
stability of the POLl transcript. Similar conclusions have
been reached about the role of the Mlu I site in cell cycle
regulation of the CDC21 gene (17).
Two other classes of genes also show bursts of RNA
synthesis in G1 phase: the HO gene, involved in mating-type
switching, and the histone genes. Previous studies have
identified the sequence CACGA4 as being necessary and
sufficient for the periodic regulation of the HO gene and the
16-bp sequence GCGA5NTRGAAC (where N is any nucle-
otide and R is a purine) as being required for the cell cycle
regulation of the histone genes (26, 27). The 54-bp sequence
present in PU1, identified here as a cell cycle-regulated UAS,
bears no obvious similarity to the consensus sequences
responsible for cell cycle regulation of the HO or histone
genes. Thus, the MCB element represents a distinct class of
cell cycle-regulatory sequence and indicates that at least
three pathways exist in yeast for the control of periodic gene
expression. Although we have shown that the Mlu I site is
necessary for cell cycle regulation, our studies do not allow
us to conclude if the 6-bp site is sufficient. However, the
observation that oligonucleotide PU5, in which the 35 bp
between the two Mlu I sites in the PU1 oligonucleotide is
missing, still works as a cell cycle-regulated UAS allows us
to limit the size of a functional MCB element to 19 bp. To
determine what sequences, if any, within this 19 bp are
required in addition to the 6-bp Mlu I site for periodic
regulation will require further experiments. That an exact
match to the 6-bp Mlu I site may not be absolutely required
is indicated by the fact that two other cell cycle-regulated
DNA synthesis genes, TS26 and PRII, do not have any Mlu
I sites in their promoters. However, PRII has two 5/6
matches and TS26 has one 5/6 match. All of these putative
MCB sites appear at approximately the same position, be-
tween -109 and -207 bp upstream of the ATG translation
start site of the respective genes. As we have shown that the
MCB site is essential for cell cycle regulation of the POLl
gene, we expect that the Mlu I and Mlu I-related sites are part
of sites responsible for cell cycle regulation of all the above
DNA metabolism genes. We do not know if there is a
difference between the regulation of promoters with one or
two Mlu I sites, but in the POLI promoter the two Mlu I sites
do not appear to act synergistically, as oligonucleotides PU2
and PU3, containing only one or the other Mlu I site, appear
to function as UASs with activities similar to the activity of
PUl oligonucleotide carrying both Mlu I sites (Fig. 2).
Sequences other than the MCB sequences (oligonucleotide
PU4) can confer transcriptional activation (Fig. 2). These
sequences do not function as a cell cycle-regulated UAS but
still appear to be repressed by the presence of a-factor (Fig.
3c, first two samples). How this repression occurs is not
known, but one possibility is that it is responding to the
presence of a-factor by way of the pheromone signal trans-
duction pathway. Irrespective of the mechanism, the data
shown in Fig. 3 suggest that the a-factor repression is
independent of the cell cycle regulation in the POLI pro-
moter.
A 37-bp deletion between the two Mlu I sites of the CDC21
promoter resulted in an 8 times reduction in transcriptional
activity (15). It is striking that a deletion between the two Mlu
I sites in the POLl promoter of a POLI-lacZ fusion gene also
resulted in a 12 times reduction in transcriptional activity to
essentially background levels. It is surprising though that
these sequences in the two promoters contain no obvious
similarities, except a high A+T content. To investigate the
possible role of the 29-bp sequence between the two Mlu I
sites in POLI further, an additional oligonucleotide (PU5)
with an internal deletion between the two Mlu I sites but with
a single reconstituted Mlu I site was constructed (see Figs. 2
and 3). PUS was indeed found to behave as a cell cycle-
regulated UAS, but the UAS activity was about 61% of that
obtained with PUL.
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FIG. 4. Data implying that at least two cis-acting sequences act
to regulate the cell cycle-regulated MCB box. One element (A) acts
negatively on the MCB UAS activity, whereas the other (o) "sup-
presses" the repression. In the wild-type promoter in pPD1-1 (a), o
and A are present allowing the cell cycle MCB box to operate.
However, in pPD1-4 (b), the o sequence is absent allowing A to
repress the MCB box and allowing little transcription to occur.
That PU5 acts as a cell cycle-regulated UAS seemed,
initially, to contradict the fact that the promoter deletion
pPD14 confers little transcriptional activity on the POLl-
lacZ gene fusion even though it contains the complete PU5
sequence. An explanation for this apparent contradiction is
offered by the fact that the presence of additional POLI
promoter sequences 5' to PU5 caused a 10 times reduction in
the amount of UAS activity obtained (see Fig. 2). This
strongly suggests that a cis-acting inhibitor of the MCB box
in PU5 is found somewhere in this 406-bp sequence. Fur-
thermore, an additional cis-acting site must be postulated that
is somehow involved in the removal of the potential MCB
repression to give the transcriptional activity found with the
intact POLI promoter. A model summarizing the cis-acting
elements involved in POL1 transcription is shown in Fig. 4.
The latter form of regulation is not without precedent.
Negative control of the S. cerevisiae HO gene must be
overridden for the cell cycle box to become active (ref. 28;
see also ref. 29; discussed in ref. 1). The negative element has
not been defined in either theHO or the POLI promoter, but
comparison of the relevant HO and POLI promoter se-
quences displayed no obvious similarities. In addition, neg-
ative control seems to account in part for the regulation of the
HTAJ-HTA2 histone genes. Deletion of a 21-bp negative
regulatory element (called the CCR) results in elevated
expression and at least partial loss of cell cycle control (27).
The CCR sequence is not found in the POLI promoter
anywhere between position -480 and the ATG. Although we
have not specifically defined the POLI negative regulatory
sequence, three copies ofthe sequence TTAAAGAA and two
copies of the sequence TCTATC occur in the region up-
stream of the Mlu I sites and might constitute additional
regulatory sequences (16).
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